Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Scientific Reports|October 26, 2018
Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalenceClaudia Alteri, Lavinia Fabeni, Rossana Scutari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levelsMaria Mercedes Santoro, Lavinia Fabeni, Daniele Armenia, et al.
Antiviral Therapy|April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimenDaniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2014
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcomeValeria Cento, Daniele Di Paolo, Domenico Di Carlo, et al.
Emerging Microbes & Infections|April 22, 2020
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels <i>in vivo</i>, hinder HBsAg secretion <i>in vitro</i> and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infectionRomina Salpini, Arianna Battisti, Lorenzo Piermatteo, et al.
Oncotarget|February 3, 2017
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitroRomina Salpini, Matteo Surdo, Nadia Warner, et al.
Plos One|May 26, 2017
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimensValeria Cento, Thi Huyen Tram Nguyen, Domenico Di Carlo, et al.
BMC Infectious Diseases|June 3, 2018
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in EuropeLuna Colagrossi, Lucas E Hermans, Romina Salpini, et al.
Pageof 4